CN104435541A - Plaster for treating shortsightedness and preparation method thereof - Google Patents

Plaster for treating shortsightedness and preparation method thereof Download PDF

Info

Publication number
CN104435541A
CN104435541A CN201410639237.4A CN201410639237A CN104435541A CN 104435541 A CN104435541 A CN 104435541A CN 201410639237 A CN201410639237 A CN 201410639237A CN 104435541 A CN104435541 A CN 104435541A
Authority
CN
China
Prior art keywords
parts
plaster
myopia
treatment
semen cuscutae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410639237.4A
Other languages
Chinese (zh)
Inventor
徐璜明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410639237.4A priority Critical patent/CN104435541A/en
Publication of CN104435541A publication Critical patent/CN104435541A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/413—Gall bladder; Bile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/614—Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Abstract

The invention discloses a plaster for treating shortsightedness. The plaster is prepared from the raw materials of calculus bovis, angelica sinensis, saffron crocus, buddleja officinalis, mulberry fruit, semen cuscutae, raspberry, blackend swallowwort root, yam rhizome, musk, rhizoma acori graminei, pearl, agate, corallium and borneol. According to the plaster for treating shortsightedness and the preparation method of the shortsightedness, pharmaceutical formulation is carefully selected according to the theory of traditional Chinese medicine and the drug percutaneous absorption technology, and the raw materials are refined according to the traditional and modern processes to obtain the plaster; the plaster can be directly applied to acupoints surrounding the eyes of a patient, and has the effects of rapidly activating blood circulation and stimulating meridians, as well as inducing resuscitation and freeing orifice; therefore, the purposes of enhancing local blood circulation, improving metabolism and improving eye muscular contraction capability to effectively improve vision rehabilitation can be reached.

Description

A kind of plaster and preparation method thereof being used for the treatment of myopia
Technical field
The invention belongs to technical field of Chinese medicine, particularly a kind of plaster and preparation method thereof being used for the treatment of myopia.
Background technology
Eye is under adjustment relaxed state, and parallel rays is by after the dioptric system flexion of eye, and be imaged on amphiblestroid front, the ametropia of this eye is called myopia.The traditional Chinese medical science is early recognized primary disease, is called " order can not hypermetropia ", and have another name called " can nearly timid disease far away ", its cause of disease be with eyesight, health asthenia (vital organs of the human body vital essence deficiency, cannot moisten eye-candy portion), its pathogenic factors with hereditary, grow, environmental factors is relevant.Harm the lighter that myopia produces shows as that blurred vision, eyes are dry and astringently ached, distraction and to dizzy, affects normal learning life; Severe one causes retinopathy, causes retina shedding, glaucoma, vitreous body to be out of shape, the severe complication such as even blind, and can entail the next generation.
Myopia is modal oculopathy in current world wide, and global myopia is more than 1,000,000,000, and China account for 30%, altogether about 300,000,000 people, be wherein group of people at high risk with teenager, main because teenager is with caused by eyestrain or congenital heredity.Theory of Chinese medical science thinks that the generation of myopia also has congenital and posteriori factor, on the one hand, blood stored in the liver, have one's ideas straightened out in order, order must not can not be looked by blood, mistake eyesight in the process of teenager life day after tomorrow study, impairment of blood by looking for a long time, blood is felt frustrated damage, asthenia of essence and blood, and in loss of nutrient of eyes so that order, God Light can not be sent out more in causing myopia at a distance; Congenital aspect, a part of myope because of father and mother's ferritic not enough, raw and innate deficiency, Liver and kidney two is empty, and God Light is weak, and brilliance can not far and and only can be near-sighted.
The methods such as the method for current correction of myopia mainly contains wearing spectacles, wears Ortho-K, external atropic category medicament dropping eye, corneal laser surgery, extract oral treatment, acupoint massage treatment.
Applicant is according to theory of Chinese medical science side, selected medical material compatibility, the method adopting tradition and modernity technique to combine makes the plaster being used for the treatment of myopia, circumference of eyes of applying ointment or plaster acupuncture point, application transdermal drag delivery, allow medicine slowly evenly discharge for a long time, entering circumference of eyes blood vessel and tissue through absorbing, reaching the object for the treatment of myopia.
Summary of the invention
The object of the present invention is to provide a kind of plaster and preparation method thereof being used for the treatment of myopia.
The technical solution used in the present invention is:
Be used for the treatment of a plaster for myopia, its raw material comprises: Calculus Bovis, Radix Angelicae Sinensis, Stigma Croci, Flos Buddlejae, Fructus Mori, Semen Cuscutae, Fructus Rubi, Radix Cynanchi Atrati, Rhizoma Dioscoreae Septemlobae, Moschus, Rhizoma Acori Graminei, Margarita, Achates, Corallium Japonicum Kishinouye, Borneolum Syntheticum.
As preferably, the weight proportion of each raw material is as follows: Calculus Bovis 1 ~ 3 part, Radix Angelicae Sinensis 8 ~ 12 parts, Stigma Croci 4 ~ 6 parts, Flos Buddlejae 8 ~ 12 parts, Fructus Mori 8 ~ 12 parts, Semen Cuscutae 10 ~ 20 parts, Fructus Rubi 10 ~ 20 parts, Radix Cynanchi Atrati 5 ~ 12 parts of, Rhizoma Dioscoreae Septemlobae 5 ~ 12 parts, 1 ~ 3 part, Moschus, Rhizoma Acori Graminei 8 ~ 12 parts, Margarita 8 ~ 12 parts, 8 ~ 12 parts, Achates, Corallium Japonicum Kishinouye 8 ~ 12 parts, Borneolum Syntheticum 18 ~ 22 parts.
As preferably, in described plaster, also contain the Mel of 18 ~ 22 parts.
Preferred further, described plaster comprises the raw material of following weight proportion: Calculus Bovis 2 parts, Radix Angelicae Sinensis 12 parts, Stigma Croci 4 parts, Flos Buddlejae 12 parts, Fructus Mori 12 parts, Semen Cuscutae 15 parts, Fructus Rubi 12 parts, Radix Cynanchi Atrati 8 parts of, Rhizoma Dioscoreae Septemlobae 8 parts, 1 part, Moschus, Rhizoma Acori Graminei 8 parts, Margarita 12 parts, 12 parts, Achates, Corallium Japonicum Kishinouye 8 parts, Borneolum Syntheticum 22 parts, Mel 18 parts.
The preparation method of above-described plaster, comprises the steps:
(1) each raw material is taken by formula;
(2) Radix Angelicae Sinensis, Stigma Croci, Flos Buddlejae, Fructus Mori, Semen Cuscutae, Fructus Rubi, Radix Cynanchi Atrati, Rhizoma Dioscoreae Septemlobae, Rhizoma Acori Graminei are dried at 85 DEG C, after propagandizing hotly with marmite, pulverizing, crosses 120 mesh sieves;
(3) by Calculus Bovis, Moschus, Margarita, Achates, Corallium Japonicum Kishinouye, Borneolum Syntheticum pulverizing respectively, 120 mesh sieves are crossed;
(4) the powder mixing after step (2) and (3) being sieved, to be placed under ultraviolet after irradiation-sterilize, to add Mel, be modulated into paste, dry, coat in blank dressing, the obtained plaster being used for the treatment of myopia.
The invention has the beneficial effects as follows:
The present invention is according to theory of Chinese medical science and Drug Percutaneous Absorption technology, selected pharmaceutical formulation, the plaster obtaining being used for the treatment of myopia is refined in conjunction with tradition and modern crafts, directly be applied to acupuncture point around eye, have and restore menstrual flow and invigorate blood circulation fast, effect that refreshment is sensible, thus reach strengthen local blood circulation, improve metabolism, strengthen eye muscle contractility, effectively improve the object of visual rehabilitation.
Prove through clinical trial, product of the present invention is used for the treatment of myopia, and recovery period is short, and cure rate is high, and determined curative effect does not rebound; It is wide that product of the present invention is suitable for crowd, is particularly suitable for teenager, to the early treatment of myope, early rehabilitation, be early benefited significant; Product use safety of the present invention, has no side effect, devoid of risk and sequela; Product of the present invention uses simple, easily popularizes, and can make more how closely to look patients benefit.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated, but be not limited thereto.
embodiment 1
Be used for the treatment of a plaster for myopia, comprise the raw material of following weight proportion: Calculus Bovis 2 parts, Radix Angelicae Sinensis 12 parts, Stigma Croci 4 parts, Flos Buddlejae 12 parts, Fructus Mori 12 parts, Semen Cuscutae 10 parts, Fructus Rubi 20 parts, Radix Cynanchi Atrati 5 parts of, Rhizoma Dioscoreae Septemlobae 12 parts, 1 part, Moschus, Rhizoma Acori Graminei 8 parts, Margarita 12 parts, 12 parts, Achates, Corallium Japonicum Kishinouye 8 parts, Borneolum Syntheticum 22 parts.
embodiment 2
Be used for the treatment of a plaster for myopia, comprise the raw material of following weight proportion: Calculus Bovis 2 parts, Radix Angelicae Sinensis 12 parts, Stigma Croci 4 parts, Flos Buddlejae 12 parts, Fructus Mori 12 parts, Semen Cuscutae 15 parts, Fructus Rubi 12 parts, Radix Cynanchi Atrati 8 parts of, Rhizoma Dioscoreae Septemlobae 8 parts, 1 part, Moschus, Rhizoma Acori Graminei 8 parts, Margarita 12 parts, 12 parts, Achates, Corallium Japonicum Kishinouye 8 parts, Borneolum Syntheticum 22 parts, Mel 18 parts.
embodiment 3
A kind of plaster being used for the treatment of myopia; comprise the raw material of following weight proportion: Calculus Bovis 1 part, Radix Angelicae Sinensis 10 parts, Stigma Croci 5 parts, Flos Buddlejae 12 parts, Fructus Mori 10 parts, Semen Cuscutae 15 parts, Fructus Rubi 12 parts, Radix Cynanchi Atrati 8 parts of, Rhizoma Dioscoreae Septemlobae 8 parts, 2 parts, Moschus, Rhizoma Acori Graminei 10 parts, Margarita 10 parts, 10 parts, Achates, Corallium Japonicum Kishinouye 10 parts, Borneolum Syntheticum 22 parts, Mel 20 parts.
embodiment 4
Be used for the treatment of a plaster for myopia, comprise the raw material of following weight proportion: Calculus Bovis 3 parts, Radix Angelicae Sinensis 8 parts, Stigma Croci 6 parts, Flos Buddlejae 8 parts, Fructus Mori 8 parts, Semen Cuscutae 20 parts, Fructus Rubi 10 parts, Radix Cynanchi Atrati 12 parts of, Rhizoma Dioscoreae Septemlobae 5 parts, 3 parts, Moschus, Rhizoma Acori Graminei 12 parts, Margarita 8 parts, 8 parts, Achates, Corallium Japonicum Kishinouye 12 parts, Borneolum Syntheticum 18 parts, Mel 22 parts.
embodiment 5
Be used for the treatment of the preparation method of the plaster of myopia described in embodiment 1 ~ 4, comprise the steps:
(1) each raw material is taken by formula;
(2) Radix Angelicae Sinensis, Stigma Croci, Flos Buddlejae, Fructus Mori, Semen Cuscutae, Fructus Rubi, Radix Cynanchi Atrati, Rhizoma Dioscoreae Septemlobae, Rhizoma Acori Graminei are dried 2 hours at 85 DEG C, after propagandizing 20 minutes hotly with marmite, pulverizing, crosses 120 mesh sieves;
(3) by Calculus Bovis, Moschus, Margarita, Achates, Corallium Japonicum Kishinouye, Borneolum Syntheticum pulverizing respectively, 120 mesh sieves are crossed;
(4) the powder mixing after step (2) and (3) being sieved, after irradiating sterilization in 30 minutes, adds Mel, is modulated into paste, dry 20 minutes, coat in blank dressing at 65 DEG C under being placed in ultraviolet, the obtained plaster being used for the treatment of myopia.
clinical trial:
1, test grouping: retrospective analysis is carried out to 1150 routine myopia populations of clinical treatment.647 examples are male, and 503 examples are women, and the age is 8 years old ~ 46 years old, the mean age 16.8, the near-sighted course of disease 1 ~ 31 year, average 8.6 years.867 people are simple myopia, 212 people's myopia companion astigmatism, and 25 people are myopia companion stravismus, and 31 people are myopia companion presbyopia, and 14 examples are myopia companion fundus flavimaculatus pathological changes, 1 example companion myasthenia gravis.1150 routine myopes are divided into three groups: low myopia (<-3D) 347 people, medium myopia (-3 ~-6D) 552 people, high myopia (>-6D) 251 people, as same patient's eyes gap is comparatively large, is then as the criterion with a poor branch hole and is included in corresponding group.Each group is divided into 4 groups again at random, and the plaster of embodiment 1-4 on probation, observes trial effect respectively.
2, test method:
Point application plaster of the present invention, acupuncture point of applying ointment or plaster: plaster prepared by the bright point application embodiment 1-4 of fair, the space between the eyebrows, Sibai, yang white, pupil, Wai Guan, nebula, applies ointment or plaster 24 hours at every turn, and every is for 10 times a course for the treatment of.Accept 5 course of therapy altogether.
3, therapeutic evaluation: adopt standard logarithmic visual acuity chart to test eyesight, optometry is surveyed vision and is responsible for by special messenger, the bias caused with the person that eliminates different measuring.Before docking the treatment of subject myope's row, after treatment, naked vision is measured and registration.Evaluation criterion be divided into healing, effective, invalid three kinds.Cure: vision >=5.0 after correction of refractive errors, asthenopia transference cure.Effective: to correct defects of vision and do not reach 5.0, but more than vision two row and two row can be improved.Invalid: without improving before and after vision treatment.
Result of the test is as shown in table 1-4:
Table 1 myope uses the plaster front-and rear-view force rate of embodiment 1 comparatively
Table 2 myope uses the plaster front-and rear-view force rate of embodiment 2 comparatively
Table 3 myope uses the plaster front-and rear-view force rate of embodiment 3 comparatively
Table 4 myope uses the plaster front-and rear-view force rate of embodiment 4 comparatively
Table 5 men and women myope therapeutic effect compares
From this group large sample quantifier elimination and basic, normal, high degree myopia group therapeutic effect, this method curative effect is distinguished, and success rate is high, has 1083 to cure completely in 1150 examples, has 62 examples effective, effective percentage 99.56%.The basic, normal, high three groups of myopia group curative effects of this research all have remarkable statistical significance through statistical analysis.Men and women's rate of myopia has certain gap, but therapeutic effect no significant difference.Without in 5 examples of positive effect after treatment, 4 examples are with fundus flavimaculatus pathological changes, 1 example companion myasthenia gravis, be the organic disease that occurs together, this also Biao Ming Shi pin mark cave in conjunction with Acupoint Application in Treating myopia by strengthening blood circulation, improve metabolism, strengthen eye muscle contractility and effectively improve vision, if but eye exists serious organic disease, then this Therapeutic Method cannot be effective.By the analysis of statistical data of this research, and contrast the therapy of other various treatment myopia, we think, Acupoint Application in Treating myopia can be considered at present effective method the most.

Claims (5)

1. be used for the treatment of a plaster for myopia, its raw material comprises: Calculus Bovis, Radix Angelicae Sinensis, Stigma Croci, Flos Buddlejae, Fructus Mori, Semen Cuscutae, Fructus Rubi, Radix Cynanchi Atrati, Rhizoma Dioscoreae Septemlobae, Moschus, Rhizoma Acori Graminei, Margarita, Achates, Corallium Japonicum Kishinouye, Borneolum Syntheticum.
2. the plaster being used for the treatment of myopia according to claim 1; it is characterized in that, the weight proportion of each raw material is as follows: Calculus Bovis 1 ~ 3 part, Radix Angelicae Sinensis 8 ~ 12 parts, Stigma Croci 4 ~ 6 parts, Flos Buddlejae 8 ~ 12 parts, Fructus Mori 8 ~ 12 parts, Semen Cuscutae 10 ~ 20 parts, Fructus Rubi 10 ~ 20 parts, Radix Cynanchi Atrati 5 ~ 12 parts of, Rhizoma Dioscoreae Septemlobae 5 ~ 12 parts, 1 ~ 3 part, Moschus, Rhizoma Acori Graminei 8 ~ 12 parts, Margarita 8 ~ 12 parts, 8 ~ 12 parts, Achates, Corallium Japonicum Kishinouye 8 ~ 12 parts, Borneolum Syntheticum 18 ~ 22 parts.
3. the plaster being used for the treatment of myopia according to claim 1 and 2, is characterized in that, the Mel also containing 18 ~ 22 parts in described plaster.
4. be used for the treatment of a plaster for myopia, it comprises the raw material of following weight proportion: Calculus Bovis 2 parts, Radix Angelicae Sinensis 12 parts, Stigma Croci 4 parts, Flos Buddlejae 12 parts, Fructus Mori 12 parts, Semen Cuscutae 15 parts, Fructus Rubi 12 parts, Radix Cynanchi Atrati 8 parts, Rhizoma Dioscoreae Septemlobae 8 parts, 1 part, Moschus, Rhizoma Acori Graminei 8 parts, Margarita 12 parts, 12 parts, Achates, Corallium Japonicum Kishinouye 8 parts, Borneolum Syntheticum 22 parts, Mel 18 parts.
5. the preparation method of the plaster described in any one of Claims 1 to 4, comprises the steps:
(1) each raw material is taken by formula;
(2) Radix Angelicae Sinensis, Stigma Croci, Flos Buddlejae, Fructus Mori, Semen Cuscutae, Fructus Rubi, Radix Cynanchi Atrati, Rhizoma Dioscoreae Septemlobae, Rhizoma Acori Graminei are dried at 85 DEG C, after propagandizing hotly with marmite, pulverizing, crosses 120 mesh sieves;
(3) by Calculus Bovis, Moschus, Margarita, Achates, Corallium Japonicum Kishinouye, Borneolum Syntheticum pulverizing respectively, 120 mesh sieves are crossed;
(4) the powder mixing after step (2) and (3) being sieved, to be placed under ultraviolet after irradiation-sterilize, to add Mel, be modulated into paste, dry, coat in blank dressing, the obtained plaster being used for the treatment of myopia.
CN201410639237.4A 2014-11-13 2014-11-13 Plaster for treating shortsightedness and preparation method thereof Pending CN104435541A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410639237.4A CN104435541A (en) 2014-11-13 2014-11-13 Plaster for treating shortsightedness and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410639237.4A CN104435541A (en) 2014-11-13 2014-11-13 Plaster for treating shortsightedness and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104435541A true CN104435541A (en) 2015-03-25

Family

ID=52882802

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410639237.4A Pending CN104435541A (en) 2014-11-13 2014-11-13 Plaster for treating shortsightedness and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104435541A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105326887A (en) * 2015-10-19 2016-02-17 于林勇 Ointment for treating myopia and preparation method and usage of ointment for treating myopia
CN107213376A (en) * 2017-08-07 2017-09-29 秦皇岛康视生物科技有限公司 A kind of ointment and preparation method for treating children myopia
CN111494348A (en) * 2020-04-15 2020-08-07 范春 Traditional Chinese medicine hydrogel eye mask and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007308398A (en) * 2006-05-17 2007-11-29 Chang Gung Memorial Hospital Eye drops and method for producing the same
CN101869640A (en) * 2010-07-02 2010-10-27 李岩 Traditional Chinese medicine for treating myopia
CN102091214A (en) * 2011-03-02 2011-06-15 朱宝民 Medicament for improving eyesight
CN103446365A (en) * 2013-07-22 2013-12-18 徐璜明 Ointment for treating myopia and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007308398A (en) * 2006-05-17 2007-11-29 Chang Gung Memorial Hospital Eye drops and method for producing the same
CN101869640A (en) * 2010-07-02 2010-10-27 李岩 Traditional Chinese medicine for treating myopia
CN102091214A (en) * 2011-03-02 2011-06-15 朱宝民 Medicament for improving eyesight
CN103446365A (en) * 2013-07-22 2013-12-18 徐璜明 Ointment for treating myopia and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
胡献国等: "《中国膏药配方配制全书》", 30 April 2014, 辽宁科学技术出版社 *
苟立成等: "清目贴防治青少年近视的临床观察", 《陕西中医》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105326887A (en) * 2015-10-19 2016-02-17 于林勇 Ointment for treating myopia and preparation method and usage of ointment for treating myopia
CN107213376A (en) * 2017-08-07 2017-09-29 秦皇岛康视生物科技有限公司 A kind of ointment and preparation method for treating children myopia
CN111494348A (en) * 2020-04-15 2020-08-07 范春 Traditional Chinese medicine hydrogel eye mask and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103446365B (en) Ointment for treating myopia and preparation method thereof
CN109045207A (en) It is a kind of for treating the eye sticker plaster and preparation method thereof of myopia
CN103083609B (en) Traditional Chinese medicine for treating cervical spondylosis, lumbar intervertebral disc herniation and ankylosing spondylitis
CN104382729A (en) Vision correction training system and method
CN100459958C (en) Chinese medicine heat therapy eyeshade and its medicine
CN104435541A (en) Plaster for treating shortsightedness and preparation method thereof
CN111035748A (en) Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia
CN106963547A (en) The intelligent eye-cover for weak sight of monitoring in real time
CN112121104B (en) Traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia
CN111494348A (en) Traditional Chinese medicine hydrogel eye mask and preparation method thereof
CN107308316A (en) A kind of medicine for treating myopia
CN107050226A (en) A kind of Chinese herb medicine eye for treating eye visual fatigue disease applies combination paste and preparation method
CN111329915B (en) Composition for relieving asthenopia of old people and hydrophilic gel thereof
RU2606180C1 (en) Method of treating and preventing myopia and accommodation spasm by badminton
CN107029037A (en) It is a kind of to improve the eyesight-improving health care function patch of eyes based on nitric oxide principle
CN106943230A (en) A kind of visual rehabilitation eyeshade
CN104997955A (en) External drug for improving myopia and its preparation method and use
CN106177130A (en) A kind of manufacture method of the Chinese medicine eye ointment treating myopia
CN111544499A (en) A topical Chinese medicinal eye ointment for treating myopia, and its preparation method
CN104096153A (en) Pharmaceutical composition containing multiple plant active ingredients and preparation method and application thereof
CN108498615A (en) A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle
CN109223919A (en) A kind of graphene precious jade medicine cover glass and preparation method thereof
CN103405609A (en) Traditional Chinese medicine preparation for treating cataract
CN106344733A (en) Eye drops for treating myopia and preparation method of eye drops
CN102836316A (en) Chinese medicine preparation for treating amblyopia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150325